Current activities of the coalition of cancer cooperative groups

Monica M. Bertagnolli, Susan M. Blaney, Charles D. Blanke, Walter J. Curran, Janet Dancey, Robert S. Mannel, Peter J. O'Dwyer, Mitchell D. Schnall, Norman Wolmark

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

The Coalition of Cancer Cooperative Groups is an organization representing the interests of patients and researchers who conduct research through the National Cancer Institute-supported National Clinical Trials Network (NCTN). The NCTN provides a crucial mechanism for executing practice-changing cancer clinical research to achieve both cancer control and development of new therapeutic agents or modality approaches. Public funding, largely through the National Cancer Institute, ensures that the work of the NCTN achieves important research that would not otherwise be accomplished in the private sector. In fall 2017, the Coalition of Cancer Cooperative Groups convened a Scientific Leadership Council to review the current state of the network with regard to research capabilities and to develop a list of research questions to be prioritized by the network. This report presents the results of this meeting, detailing a roadmap for future work by the NCTN.

Original languageEnglish (US)
Article numberdjy190
JournalJournal of the National Cancer Institute
Volume111
Issue number1
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Current activities of the coalition of cancer cooperative groups'. Together they form a unique fingerprint.

Cite this